AIG
AEGR

American International Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

American International Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,686
Closed -$54K – 4934
2016
Q1 		$54K Sell
14,686
-5,865
-29% -$36.3K ﹤0.01% 3849
2015
Q4 		$207K Buy
20,551
+5,839
+40% +$70.3K ﹤0.01% 2798
2015
Q3 		$200K Buy
14,712
+17
+0.1% +$303 ﹤0.01% 2836
2015
Q2 		$279K Sell
14,695
-3,844
-21% -$83.2K ﹤0.01% 2712
2015
Q1 		$485K Hold
18,539
– – ﹤0.01% 2184
2014
Q4 		$388K Sell
18,539
-732
-4% -$18.4K ﹤0.01% 2363
2014
Q3 		$643K Sell
19,271
-15
-0.1% -$466 ﹤0.01% 1913
2014
Q2 		$619K Sell
19,286
-311
-2% -$11.6K ﹤0.01% 1981
2014
Q1 		$904K Buy
19,597
+471
+2% +$27.6K ﹤0.01% 1602
2013
Q4 		$1.36M Sell
19,126
-192
-1% -$14.7K 0.01% 1271
2013
Q3 		$1.66M Sell
19,318
-86
-0.4% -$7.29K 0.01% 1120
2013
Q2 		$1.23M Buy
+19,404
New +$1.03M 0.01% 1266

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American International Group's AEGR Position: Q2 2016 in Review

American International Group sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 14,686 shares — an estimated $54K sold.

American International Group first reported a position in AEGR in Q2 2013 and held it in 12 quarters. The position peaked at $1.66M in Q3 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • American International Group reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 14,686 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $54K.
  • American International Group first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • American International Group's Aegerion Pharmaceuticals position peaked at $1.66M in Q3 2013.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.